To address this latter methodological issue, Marangell and colleagues administered intrathecal TRH to eight patients with treatment-resistant MDD and measured the onset of antidepressant effects using an abbreviated version of the HAM-D [110]. The gene discussed is TRH; the disease is major depressive disorder.